OraSure Technologies Inc (OSUR)
5.25
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
5.30
+0.05
(+0.95%)
After-Hours: 07:00
OraSure Technologies Cash from Financing (TTM): -3.023M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.023M |
| September 30, 2023 | -3.469M |
| June 30, 2023 | -3.252M |
| March 31, 2023 | -3.764M |
| December 31, 2022 | -3.828M |
| September 30, 2022 | -2.792M |
| June 30, 2022 | -2.826M |
| March 31, 2022 | -2.028M |
| December 31, 2021 | -2.817M |
| September 30, 2021 | -2.123M |
| June 30, 2021 | -0.225M |
| March 31, 2021 | 94.85M |
| December 31, 2020 | 92.48M |
| September 30, 2020 | 91.39M |
| June 30, 2020 | 89.88M |
| March 31, 2020 | -4.907M |
| December 31, 2019 | -4.682M |
| September 30, 2019 | -4.913M |
| June 30, 2019 | -4.304M |
| March 31, 2019 | -4.218M |
| December 31, 2018 | -1.891M |
| September 30, 2018 | -1.23M |
| June 30, 2018 | 8.66M |
| March 31, 2018 | 19.86M |
| December 31, 2017 | 30.44M |
| Date | Value |
|---|---|
| September 30, 2017 | 31.80M |
| June 30, 2017 | 21.75M |
| March 31, 2017 | 10.60M |
| December 31, 2016 | -1.155M |
| September 30, 2016 | -7.711M |
| June 30, 2016 | -8.029M |
| March 31, 2016 | -8.222M |
| December 31, 2015 | -5.686M |
| September 30, 2015 | -0.19M |
| June 30, 2015 | 0.154M |
| March 31, 2015 | 0.253M |
| December 31, 2014 | 0.476M |
| September 30, 2014 | -0.013M |
| June 30, 2014 | -0.357M |
| March 31, 2014 | -0.406M |
| December 31, 2013 | -0.42M |
| September 30, 2013 | 0.016M |
| June 30, 2013 | 68.54M |
| March 31, 2013 | 70.41M |
| December 31, 2012 | 71.43M |
| September 30, 2012 | 72.79M |
| June 30, 2012 | 4.554M |
| March 31, 2012 | 4.326M |
| December 31, 2011 | 3.374M |
| September 30, 2011 | 1.367M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-4.913M
Minimum
Sep 2019
94.85M
Maximum
Mar 2021
16.82M
Average
-2.826M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
| Abbott Laboratories | -7.091B |
| Integra Lifesciences Holdings Corp | -229.92M |
| Insulet Corp | -13.60M |
| Perspective Therapeutics Inc | 0.785M |
| Xtant Medical Holdings Inc | 19.69M |